Metabolic Health as an Essential Consideration When Using Antipsychotic Medications
Activity Description:
Antipsychotic medications may induce or worsen metabolic abnormalities such as weight gain, glucose dysregulation, and hyperlipidemia. Action should be taken to minimize metabolic-related risks of antipsychotic medications whenever possible. Such actions may include choosing agents with a lower propensity to impact metabolic parameters and routinely monitoring for metabolic disturbances. Although the rationale for metabolic monitoring remains clear and consistent, monitoring rates have been shown to be less than optimal, regardless of antipsychotic formulation. This written continuing education activity summarizes evidence-based strategies for the prevention and management of metabolic side effects of antipsychotic medications.
Learning Objectives:
- Discuss the metabolic side effects associated with use of antipsychotic medications.
- Identify appropriate monitoring parameters and schedules for metabolic side effects in patients treated with antipsychotic medications.
- Describe strategies for the management of metabolic side effects of antipsychotic medications.
Intended Audience: Physicians, physician assistants, nurse practitioners, pharmacists, and other healthcare providers.
Initial Release Date: 5/22/2024
Expiration Date: 5/21/2027
Faculty:
Accreditation Information:
For physicians/providers:
Accreditation: The University at Buffalo Jacobs School of Medicine and Biomedical Sciences is accredited by the ACCME to provide continuing medical education for physicians.
Certification: The University at Buffalo Jacobs School of Medicine and Biomedical Sciences designates this Internet Enduring Activity for a maximum of 1.0 AMA PRA Category 1 Credit (TM). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For pharmacists:
The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based activity has been assigned ACPE# 0044-9999-24-018-H01-P and will award 1.0 contact hour (0.10 CEU) of continuing pharmacy education credit. Credit will be uploaded to the CPE Monitor for those who complete all components of this activity.
Activity Components for Continuing Education Credit:
To obtain continuing education credit, complete the required materials. This continuing education activity contains a pre-test, written article, post-test, and program evaluation. Credit will be awarded upon successful completion of the post-test activity, with a score of over 70%.
Disclosures:
The following planners, presenters and others have either indicated financial relationships with ineligible companies or that no financial relationships exist. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. ACCME Standards for Integrity and Independence in Accredited Continuing Education
| The following planners/presenters/others do not have any relevant financial relationships with ineligible companies: | |
| Role in Activity | Name |
| Planner | Edward M. Bednarczyk, PharmD |
| Planner, Author, Reviewer | Tammie Lee Demler, PharmD, MBA, BCGP, BCPP |
| Planner | Marsha Nelson |
| Reviewer | Barbara Rogler, PharmD, MS |
| Activity Director, Reviewer, Author | Alexia Sroka, PharmD, BCPS |
| Planner, Reviewer | Deborah Targoff, PharmD |
| Commercial support for this activity (include the name of the ineligible company and nature of the support OR check the box "None") |
| X None |
Software Requirements:
- Chrome
- Firefox
- Safari
- Edge
- Internet Explorer is NOT supported
- Safari 7 and below has known compatibility issues
- Smartphones have limited support. Use a desktop or laptop computer for the best experience.
- Safari
- Chrome
For questions about this activity, please contact: pep@nysdoh.suny.edu